TD Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-19,290
Closed -$861K – 1224
2026
Q2
$861K Hold
19,290
– – ﹤0.01% 1113
2026
Q1
$995K Sell
19,290
-4,510
-19% -$316K ﹤0.01% 1091
2025
Q4
$2.2M Buy
+23,800
New +$2.28M ﹤0.01% 949
2024
Q4
– Sell
-15,284
Closed -$3.09M – 1330
2024
Q3
$3.09M Sell
15,284
-12,600
-45% -$2.19M ﹤0.01% 904
2024
Q2
$3.73M Sell
27,884
-3,504
-11% -$663K ﹤0.01% 833
2024
Q1
$6.74M Buy
31,388
+21,788
+227% +$4.27M 0.01% 703
2023
Q4
$1.95M Buy
+9,600
New +$1.56M ﹤0.01% 1021
2019
Q2
– Sell
-9,861
Closed -$560K – 1342
2019
Q1
$560K Buy
9,861
+300
+3% +$16.2K ﹤0.01% 1164
2018
Q4
$404K Buy
+9,561
New +$406K ﹤0.01% 1262

Other funds holding INSP

TD Asset Management's INSP Position: Q3 2026 in Review

TD Asset Management sold out of Inspire Medical Systems (INSP) in Q3 2026, closing a stake of 19,290 shares — an estimated $861K sold.

TD Asset Management first reported a position in INSP in Q4 2018 and held it in 9 quarters. The position peaked at $6.74M in Q1 2024. 308 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • TD Asset Management reported no remaining Inspire Medical Systems position as of Q3 2026 after selling out during the quarter.
  • TD Asset Management sold 19,290 Inspire Medical Systems shares in Q3 2026, an estimated $861K.
  • TD Asset Management first reported a position in Inspire Medical Systems in Q4 2018 and held it in 9 quarters.
  • TD Asset Management's Inspire Medical Systems position peaked at $6.74M in Q1 2024.
  • 308 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.